Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy
Clinical and Translational Medicine · 2025
DOI: 10.1002/ctm2.70318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Ying Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Acad…. Hauptthemen laut MEDLINE: MEF2 Transcription Factors, Myocardial Ischemia, Cardiomyopathies, Cysteine Endopeptidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ischemic cardiomyopathy (ICM) is characterised by the insufficient capacity of the heart to effectively pump blood, which ultimately contributes to heart failure (HF). In this study, the down regulation of SENP1 is identified in the cardiomyocyte of ICM mouse models and in patients. The depletion of SENP1 exacerbates hypoxia‐induced apoptosis of cardiomyocytes in vitro and deteriorated cardiomyocyte injury of ICM mice in vivo. Mechanistically, SENP1 deSUMOylates the SUMO2‐mediated modification of MEF2C at lysine 401 for stabilising protein stability. Moreover, the interaction with SENP1 controls the nuclear condensation of MEF2C to promote the expression of genes critical for cardiomyocyte function. When rescuing SENP1 expression using adeno‐associated virus serotype 9, the attenuation of cardiomyocyte injury is discerned in the mouse model of ICM. Therefore, these finding elicits a previously unrecognised role and mechanism of SENP1 in safeguarding cardiomyocyte in ICM progression while establishing a basis for the development of SENP1 as a potential marker for ICM diagnosis and treatment. Key points SNEP1 is downregulated in the cardiomyocyte of ICM mouse models and in patients. SENP1 deSUMOylates the SUMO2‐mediated modification of MEF2C at lysine 401 for protein stability. The interaction with SENP1 controls the nuclear condensation of MEF2C to promote cardiomyocyte function. Cardiac rescue of SENP1 alleviates ischemic heart injury in ICM mouse models by AAV9.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- Tianjin Key Laboratory of Epigenetics for Organ Development in Preterm Infants, The Tianjin Fifth Central Hospital, Binhai, Tianjin, China.
- Ultrasound Imaging Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Yunlong Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xie, Y., Li, Q., Bian, X., Yin, Y., Liang, Z., Liu, X., Zhang, T., Liu, X., Quan, X., & Wang, Y. (2025). Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70318
Vancouver
Xie Y, Li Q, Bian X, Yin Y, Liang Z, Liu X, et al. Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70318
BibTeX
@article{Xie2025,
author = {Xie, Ying and Li, Qiaoyuan and Bian, Xiyun and Yin, Yan and Liang, Zhuo and Liu, Xu and Zhang, Tao and Liu, Xiaozhi and Quan, Xin and Wang, Yunlong},
title = {Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy},
journal = {Clinical and Translational Medicine},
year = {2025},
doi = {10.1002/ctm2.70318}
}
EUVIMED